SHAREHOLDERS' DEFICIT

9 Months Ended

Mar. 31, 2024

Stockholders' Equity Note [Abstract]

SHAREHOLDERS' DEFICIT:

Stock-Based Employee Compensation:

During the three and nine months ended March 31, 2024, the Company granted restricted stock units as follows:


	Three Months Ended March 31, 2024	Nine Months Ended March 31, 2024

Restricted stock units (RSUs)	—	12,970

The RSUs granted during the nine months ended March 31, 2024, vest in equal amounts over a three-year period subsequent to the grant date.

Total compensation cost for stock-based payment arrangements totaling $0.3 million and $0.6 million for the three months ended March 31, 2024 and 2023, respectively, and $1.2 and $1.7 million for the nine months ended March 31, 2024 and 2023, respectively, was recorded within general and administrative on the unaudited Condensed Consolidated Statements of Operations.

Share Issuance Program:

In fiscal year 2021, the Company filed a $150.0 million shelf registration statement and $50.0 million prospectus supplement (collectively, the Share Issuance Program) with the Securities and Exchange Commission (SEC) under which it may offer and sell, from time to time, up to $50.0 million worth of its Class A common stock in "at-the-market" offerings. During the three and nine months ended March 31, 2024 and 2023, the Company did not issue any shares under this prospectus. The Share Issuance Program expired on February 10, 2024.